Hyperphosphataemia, a common biochemical abnormality in chronic kidney disease, poses significant management challenges. This study aims to determine whether the reasons for this are multifactorial; including poor dietary knowledge, poor adherence to a low phosphate diet and phosphate-binding medications and the impact of age on these parameters.
In order to compare serum phosphate and other associated parameters to the UK Renal Association Clinical Practice Guidelines 2010 an audit and service evaluation questionnaire was carried out in May 2011 on 130 haemodialysis outpatients attending the Plymouth Dialysis Unit.
Fifty-three percent of patients had serum phosphate within the target range of 1.1–1.7 mmol/l, 77% and 85% had serum calcium and parathyroid hormone within target ranges, respectively. Younger patients (18–45years) were significantly less likely to have serum phosphate within range χ2 (2, n=124)=18.77, P<0.001. Despite better knowledge of their own phosphate levels (P=0.005), phosphorus-rich foods (P<0.001), symptoms of hyperphosphataemia (P<0.001) and increased use of Renal Patient View (P=0.002), <65 years old had significantly higher phosphate levels than those >65 years (P<0.001). No significant associations were found between phosphate control and the following factors: gender, timing of dialysis shift, years on dialysis or dialysis adequacy.
In this population, despite better knowledge, younger patients have worse phosphate control than older patients. Using the same dietary education techniques may not be suitable for all ages, more innovative approaches supported by skilled health professionals are needed to motivate and engage with younger patients to promote self-management and adherence.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Block G, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208–2218.
UK Renal Association. Clinical Practice Guideline: CKD-Mineral and Bone Bisorders (CKD-MBD). The Renal Association: Oxford, UK, 2010.
Touissant ND, Pedagogos E, Beavis J, Becker GJ, Polkinghorne KR, Kerr PG . Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant 2011; 26: 1319–1326.
Lynch KE, Lynch R, Curhan GC, Brunelli SM . Prescribed dietary phosphate restriction and survival among haemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 620–629.
Cupisti A, Ferretti V, D’Alessandro C, Petrone I, Di Giorgio A, Meola M et al. Nutritional knowledge in haemodialysis patients and nurses: focus on phosphorus. J Ren Nutr 2012; 22: 541–546.
Kugler C, Maeding I, Russell CL . Non-adherence in patients on chronic haemodialysis: an international comparison study. J Nephrol 2011; 24: 366–375.
Nerbass FB, Morais JG, dos Santos RG, Kruger TS, Koene TT, da Luz Filho HA . Adherence and knowledge about hyperphosphataemia treatment in haemodialysis patients with hyperphosphataemia. J Bras Nefrol 2010; 32: 149–155.
Poduval RD, Wolgemuth D, Ferrel J, Hammes MS . Hyperphosphataemia in dialysis patients: is there a role for focused counselling? J Ren Nutr 2003; 13: 219–223.
Chui Y, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R . Pill burden, adherence, hyperphosphataemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1089–1096.
Tomasello S, Dhupar S, Sherman RA . Phosphate binders. K/DOQI guidelines and compliance: the unfortunate reality. Dialysis Transplant 2004; 33: 236–242.
Karamanidou C, Clatworthy J, Weinman J, Horne R . A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 2008; 9: 2.
Pruthi R, Pitcher D, Dawnay A . 14th Annual Report of the Renal Association. Renal Registry: Bristol, UK, 2011.
Bame SI, Petersen N, Wray NP . Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med 1993; 37: 1035–1043.
Bossola M, Muscaritoli M, Tazza L, Panocchia N, Liberatori M, Giungi S et al. Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr 2005; 15: 244–252.
DiMatteo MR . Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200–209.
Sun Y, Cai H, Bai J, Zhao H, Miao Y . Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: a new surgical approach. World J Surg 2009; 33: 1674–1679.
Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM et al. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 2008; 23: 2319–2323.
Leypoldt JK . Kinetics of beta2-microglobulin and phosphate during haemodialysis: effects of treatment frequency and duration. Semin Dial 2005; 18: 401–408.
Stamatakis MK, Pecora PG, Gunel E . Factors influencing adherence in chronic dialysis patients with hyperphosphatemia. J Ren Nutr 1997; 7: 144–148.
Park K, Choi-Kwon S, Sim YM, Kim SB . Comparison of dietary compliance and dietary knowledge between older and younger Korean haemodialyis patients. J Ren Nutr 2008; 18: 415–423.
Durose CL, Holdsworth M, Watson V, Przygrodzka F . Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on haemodialysis are no predictive of dietary compliance. J Am Diet Assoc 2004; 104: 35–41.
Goldfarb S . Renal Osteodystrophy, Disorders of divalent ions, and nephrolithiasis. Nephrology Self-Assessment Program. J Am Soc Nephrol 2005; 4: 245–279.
Reddy V, Sethi N, Scally A, Symes F, Steel J, Mumtaz R et al. Dietitian-led education programme to improve phosphate control in a single-centre haemodialysis population. J Ren Nutr 2009; 19: 314–320.
Cupisti A, D’Alessandro C, Baldi R, Barsotti G . Dietary habits and counselling focused on phosphate intake in haemodialysis patients with hyperphosphataemia. J Ren Nutr 2004; 14: 220–225.
National Institute for Health and Care Excellence (NICE). Hyperphosphataemia in Chronic Kidney Disease Management of Hyperphosphataemia in Patients with Stage 4 or 5 Chronic Kidney Disease. CG157, National Institute for Health and Care Excellence: London, UK, 2013.
Kuhlmann MK, Hoechst S, Landthaler I . Patient empowerment in the management of hyperphosphataemia. Int J Art Org 2007; 30: 1008–1013.
Morey B, Walker R, Devenport A . More dietetic time, better outcome? A randomised prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008; 109: 173–180.
Kalantar-Zadeh K . Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence 2013; 7: 379–390.
Caldeira D, Amaral T, David C, Sampaio C . Educational strategies to reduce serum phosphorus in hyperphosphataemic patients with chronic kidney disease: systematic review with meta-analysis. J Ren Nutr 2011; 21: 285–294.
Karamanidou C, Weinman J, Hore R . Improving haemodialysis patients’ understanding of phosphate binding medication: a pilot study of a psycho-educational intervention designed to change patients’ perceptions of the problem and treatment. Brit J Health Psych 2008; 13: 205–214.
Carlson S, Benner D, Kwiterovich C, Van Wyck D . Patient experience with an interactive web-based phosphorous education tool. J Ren Nutr 2011; 21: 205.
Elwood D The right technology improves patient education and satisfaction. Mobile health 360. 2011. (accessed December 7, 2012 at http://www.mhealth360.com/2011/03/14/the-right-technology-improves-patient-education-and-satisfaction/).
We would like to acknowledge the haemodialysis patients for their participation and the following final year dietetics students; Annie Fitzpatrick, Sarah Evans and Janine Machin, for contributing in data collection.
The authors declare no conflict of interest.
About this article
Cite this article
Collinson, A., McMullan, M., Tse, W. et al. Managing serum phosphate in haemodialysis patients: time for an innovative approach?. Eur J Clin Nutr 68, 392–396 (2014). https://doi.org/10.1038/ejcn.2013.283
- serum phosphate
This article is cited by
Der Nephrologe (2017)
European Journal of Clinical Nutrition (2014)
European Journal of Clinical Nutrition (2014)
Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure
Journal of Nephrology (2014)